KRSNAA NSE filing

Krsnaa Diagnostics to meet with Sanlam Limited and Haitong securities on Sept 8, 2025

The RealCase readLow impact Neutral

Why it matters

Meetings with investors are a normal part of investor relations and have a limited immediate impact on the company's stock price or operations.

The market read

The announcement is about investor meetings, which is a routine corporate activity and does not inherently indicate a positive or negative outlook.

* Krsnaa Diagnostics Limited will be meeting with investors/analysts. * On September 8, 2025, the company will have a one-on-one virtual interaction with Sanlam Limited at 14:30 Hrs (IST). * Followed by Haitong securities at 16:00 Hrs (IST). * Discussions will be based on publicly available information, and no unpublished price-sensitive information (UPSI) is intended to be discussed.

Filing to action

What to do with a filing like this

Krsnaa Diagnostics Limited filed this with the NSE as a statutory disclosure, categorised under agm-egm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Krsnaa Diagnostics Limited. Read the original for the full detail.

View original filing